三胎妊娠合并双胎输血综合征胎儿镜下激光手术的围产期结局:队列研究、系统综述与Meta分析
本研究在两个胎儿中心回顾性分析2012至2020年间31例接受胎儿镜下激光光凝术的三胎妊娠合并双胎输血综合征病例(24例双绒毛膜三羊膜囊、7例单绒毛膜三羊膜囊),并进行系统综述与Meta分析。结果显示两组围产期生存率无显著差异,但三胎妊娠合并双胎输血综合征整体早产和不良围产结局风险高。
要点
- 三胎妊娠合并双胎输血综合征接受胎儿镜下激光光凝术后,双绒毛膜三羊膜囊与单绒毛膜三羊膜囊组的围产期生存率无显著差异。
- 系统综述显示双绒毛膜三羊膜囊三胎的胎儿生存率为79%(95%CI 75-83%),单绒毛膜三羊膜囊为74%(95%CI 52-92%)。
- 三胎妊娠合并双胎输血综合征早产风险高,双绒毛膜三羊膜囊组32周前早产率为61%(95%CI 50-72%)。
核心结论
- 三胎妊娠合并双胎输血综合征无论绒毛膜性如何,均存在不良围产结局和早产的高风险;本研究中单绒毛膜三羊膜囊三胎激光光凝术后生存率高于既往报道,目前与双绒毛膜三羊膜囊三胎相当,可能归因于手术技巧的改善。
研究设计与样本
- 第一部分为回顾性队列研究,纳入2012至2020年间在两个胎儿治疗中心前瞻性收集的连续31例接受胎儿镜下激光光凝术的三胎妊娠合并双胎输血综合征病例(24例双绒毛膜三羊膜囊、7例单绒毛膜三羊膜囊);第二部分为系统综述与Meta分析,检索PubMed、Web of Science和Scopus从建库至2020年9月,纳入9项研究(包括本队列),共156例双绒毛膜三羊膜囊和37例单绒毛膜三羊膜囊三胎妊娠接受胎儿镜下激光光凝术。
诊断标准与关键数值
- 系统综述中双绒毛膜三羊膜囊三胎的总体胎儿生存率为79%(95%CI 75-83%),新生儿生存率为75%(95%CI 71-79%)。
- 系统综述中单绒毛膜三羊膜囊三胎的总体胎儿生存率为74%(95%CI 52-92%),新生儿生存率为71%(95%CI 49-89%)。
- 双绒毛膜三羊膜囊三胎28周前和32周前早产率分别为14%(95%CI 4-29%)和61%(95%CI 50-72%)。
- 单绒毛膜三羊膜囊三胎28周前和32周前早产率分别为21%(95%CI 3-45%)和82%(95%CI 62-96%)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aims of this study were to investigate the perinatal outcome of dichorionic triamniotic (DCTA) and monochorionic triamniotic (MCTA) triplet pregnancies complicated by twin-twin transfusion syndrome (TTTS) treated with fetoscopic laser photocoagulation (FLP) in two academic fetal centers, and to conduct a systematic review of previously published data to investigate perinatal survival in this targeted population.
METHODS: The first part of the study was a retrospective cohort study of prospectively collected data of consecutive triplet pregnancies with TTTS that underwent FLP at two fetal treatment centers between 2012 and 2020. Demographic, preoperative and operative variables and postoperative outcome were collected. Perinatal outcomes were investigated. The second part of the study was a systematic review and meta-analysis of studies evaluating the outcome of DCTA and/or MCTA triplet pregnancies, including our cohort study. PubMed, Web of Science and Scopus were searched from inception to September 2020. Primary outcomes were fetal survival (survival to birth), neonatal survival (survival to 28 days of age) and gestational age (GA) at birth.
RESULTS: A total of 31 sets of triplets with TTTS managed with FLP were included in the cohort study. Of these, 24 were DCTA and seven were MCTA. There were no significant differences in preoperative and operative variables between the two groups. There were also no significant differences between groups in GA at delivery or perinatal survival rate, including fetal and neonatal survival of at least one triplet, at least two triplets and all three triplets. Nine studies, including our cohort study, were included in the systematic review (156 DCTA and 37 MCTA triplet pregnancies treated with FLP). The overall fetal and neonatal survival was 79% (95% CI, 75-83%) and 75% (95% CI, 71-79%), respectively, in DCTA cases and 74% (95% CI, 52-92%) and 71% (95% CI, 49-89%), respectively, in MCTA cases. The rate of preterm birth before 28 weeks and before 32 weeks' gestation was 14% (95% CI, 4-29%) and 61% (95% CI, 50-72%), respectively, in DCTA triplets and 21% (95% CI, 3-45%) and 82% (95% CI, 62-96%), respectively, in MCTA triplets.
CONCLUSIONS: Triplet pregnancies with TTTS are at high risk of adverse perinatal outcome and preterm birth, regardless of chorionicity. The rate of survival after FLP in MCTA triplets was higher in our study than that reported in previous studies and is currently comparable with survival in DCTA triplets, which could be due to improved surgical skills. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Mustafa HJ, Javinani A, Krispin E, et al. Perinatal outcomes of fetoscopic laser surgery for twin-twin transfusion syndrome in triplet pregnancy: cohort study, systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 35229918. doi:10.1002/uog.24887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。